Tuba Tüylü Küçükkılınç

8PUBLICATIONS
15CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Biologically active moleculesMolecular medicineToxicology (incl. clinical toxicology)Nanotoxicology, health and safety
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Jul 09, 2026
Zeaxanthin Mitigates Hydroxychloroquine-Induced Retinal Toxicity and Metabolic Reprogramming in ARPE-19 Cells.

|Jul 21, 2024
Novel 1,2,4-triazole derivatives containing the naphthalene moiety as selective butyrylcholinesterase inhibitors: Design, synthesis, and biological evaluation.

Ebru Koçak Aslan, Aysima Sezer, Tuba Tüylü Küçükkılınç

|Mar 05, 2024
4-{3-[(Pyridin-4-ylmethyl)amino]-[1,2,4]triazolo[4,3-b][1,2,4]triazin-6-yl}phenol: An improved anticancer agent in hepatocellular carcinoma and a selective MDR1/MRP modulator.

Zahra Zakeri Khatir, Antonella Di Sotto, Ester Percaccio

|May 29, 2023
Phenelzine protects against acetaminophen induced apoptosis in HepG2 cells.

Tuba Tüylü Küçükkılınç, Ayşe Ercan

|Jun 08, 2021
Combined effect of fulvestrant and low dose BPA: comparative implications on EMT, apoptosis, and TGF-β1 signaling in HepG2 cells.

Esin Öz, Tuba Tüylü Küçükkılınç

|Apr 19, 2021
Hybridization-based design of novel anticholinesterase indanone-carbamates for Alzheimer's disease: Synthesis, biological evaluation, and docking studies.

Mohammad Shahrivar-Gargari, Maryam Hamzeh-Mivehroud, Salar Hemmati

Pageof 2

Frequent Collaborators

1 joint publications

Antonella Di Sotto

1 joint publications

Ann M Chippindale

1 joint publications

Mehdi Valipour

1 joint publications

Hamid Irannejad